Evidence map›Paper›PMID 32924099›Full record

ArticleDrug delivery and translational research2020

Bicontinuous microemulsions containing Melaleuca alternifolia essential oil as a therapeutic agent for cutaneous wound healing.

Karoll Moangella Andrade de Assis, Joandra Maísa da Silva Leite, Demis Ferreira de Melo, Joyce Cordeiro Borges, Lucas Matheus Barreto Santana, Malu Maria Lucas Dos Reis, Vandiara Martins Moreira, Wilma Rainny Vieira da Rocha, Raïssa Mayer Ramalho Catão, Sócrates Golzio Dos Santos and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. A formulation containingBeilstein journal of nanotechnology · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Karoll Moangella Andrade de AssisGraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.ORCID 0000-0003-0673-522X
Joandra Maísa da Silva LeiteGraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.ORCID 0000-0003-3647-7081
Demis Ferreira de MeloGraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.ORCID 0000-0001-8486-5578
Joyce Cordeiro BorgesLaboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil.ORCID 0000-0002-9773-5884
Lucas Matheus Barreto SantanaLaboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil.ORCID 0000-0002-2073-0735
Malu Maria Lucas Dos ReisGraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.ORCID 0000-0003-4480-680X
Vandiara Martins MoreiraGraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.ORCID 0000-0001-9077-5376
Wilma Rainny Vieira da RochaLaboratory of Microbiology, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil.ORCID 0000-0001-8126-8153
Raïssa Mayer Ramalho CatãoLaboratory of Microbiology, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil.ORCID 0000-0001-6077-8824
Sócrates Golzio Dos SantosResearch Institute for Drugs and Medicines, Federal University of Paraíba, João Pessoa, Paraíba, Brazil.ORCID 0000-0002-8458-8731
Alyne da Silva PortelaMedical Sciences Faculty, University Center UniFacisa, Campina Grande, Paraíba, Brazil.ORCID 0000-0001-5642-8979
Samantha Mayara de Sousa SilvaMedical Sciences Faculty, University Center UniFacisa, Campina Grande, Paraíba, Brazil.
Tharcia Kiara Beserra de OliveiraMedical Sciences Faculty, University Center UniFacisa, Campina Grande, Paraíba, Brazil.ORCID 0000-0001-6352-7254
João Walter de Souza da SilveiraGraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.ORCID 0000-0002-1688-0917
Emanuene Galdino PiresDepartment of Dentistry, State University of Paraíba, Campina Grande, Paraíba, Brazil.ORCID 0000-0001-6409-7428
Cassiano Francisco Weege NonakaDepartment of Dentistry, State University of Paraíba, Campina Grande, Paraíba, Brazil.ORCID 0000-0003-2380-109X
Fátima Aparecida Castriani SanchesGraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.ORCID 0000-0003-1075-4992
Bolívar Ponciano Goulart de Lima DamascenoGraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil. bolivarpgld@hotmail.com.ORCID 0000-0002-0747-0297
Universidade Estadual da Paraíba · BRUniversidade Federal da Paraíba · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

The Melaleuca alternifolia essential oil (MEO) has been widely used due to its healing and antimicrobial action. Its incorporation into drug delivery systems is a reality, and numerous studies have already been developed for this purpose. In this regard, the aim of this work was to develop, characterize, and evaluate the in vivo pharmacological activity of bicontinuous microemulsions (BME) containing MEO. Through diagram construction, a formulation consisting of Kolliphor® HS 15 (31.05%), Span® 80 (3.45%), isopropyl myristate (34.5%), and distilled water (31%) was selected and MEO was incorporated in the proportion of 3.45% (v/v). Morphological analysis characterization confirms that the system studied herein is a BME. The evaluated formulation showed physicochemical characteristics that allow its topical use. Rheologically, samples were characterized as pseudo-plastic non-Newtonian thixotropic fluids. The chromatographic method developed is in accordance with the current recommendations. The extraction method used assured a 100% recovery of the pharmacological marker (terpinen-4-ol). In vivo studies suggest that BME loaded with MEO may contribute to the healing process of skin wounds. In addition, it demonstrated antibacterial activity for Gram-positive and Gram-negative bacteria. Therefore, the BME system loaded with MEO is promising as a healing and antimicrobial agent for skin wounds.Graphical abstract.

Indexed as

Anti-Bacterial AgentsMelaleucaTea Tree OilGram-Negative BacteriaGram-Positive BacteriaWound HealingAnti-Bacterial AgentsTea Tree OilAntibacterial activityDrug delivery systemsPharmacological effectsPhysicochemical characterizationTea tree

Identifiers

PMID32924099
OpenAlexW3084845410

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.